Skip to main content

MoneyWorks4Me

Thyrocare Technologies informs about analyst meet

08 Feb 2018 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that a conference call for the Indian and overseas analysts is arranged by management to discuss the Company's unaudited financial results Quarter / Nine Months ended December 31, 2017, on Friday, February 09, 2018 at 2.30 pm local time. Dr Velumani A., Ph.D., CEO, A. Sundararaju, CFO, Sachin Salvi, GM-Finance and Vatsal Goyal- Head- Strategy and Corporate Development, will represent the Company.

The above information is a part of company’s filings submitted to BSE.

Peers